Back to ACAD
PROFUND ADVISORS LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$853K
Q3 2026
Peak value
$2.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $980K |
| Q4 2025 | $2.1M |
| Q1 2026 | $1.9M |
| Q2 2026 | $1.5M |
| Q3 2026 | $853K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $853K | 42.3K | — | — |
| Q2 2026 | $1.5M | 60.8K | — | — |
| Q1 2026 | $1.9M | 84.5K | — | — |
| Q4 2025 | $2.1M | 77.1K | — | — |
| Q3 2025 | $980K | 45.9K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M